Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of GBP 805.02 million. The enterprise value is 824.68 million.

Market Cap	805.02M
Enterprise Value	824.68M

Important Dates

The next estimated earnings date is Wednesday, April 1, 2026.

Earnings Date	Apr 1, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	48.22M
Shares Outstanding	n/a
Shares Change (YoY)	+10.33%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	5.92%
Float	30.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	92.44
PB Ratio	-13.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-18.63
EV / Sales	92.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.41

Financial Position

The company has a current ratio of 0.63

Current Ratio	0.63
Quick Ratio	0.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.62
Interest Coverage	-5.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.64%
Return on Invested Capital (ROIC)	-567.28%
Return on Capital Employed (ROCE)	245.90%
Revenue Per Employee	84,546
Profits Per Employee	-429,787
Employee Count	108
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	-31,716
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +481.70% in the last 52 weeks. The beta is 1.32, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	+481.70%
50-Day Moving Average	18.78
200-Day Moving Average	8.85
Relative Strength Index (RSI)	54.45
Average Volume (20 Days)	15,489

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanobiotix had revenue of GBP 8.71 million and -44.27 million in losses. Loss per share was -0.93.

Revenue	8.71M
Gross Profit	8.71M
Operating Income	-37.65M
Pretax Income	-44.30M
Net Income	-44.27M
EBITDA	-37.58M
EBIT	-37.65M
Loss Per Share	-0.93

Full Income Statement

Balance Sheet

The company has 24.70 million in cash and 43.92 million in debt, giving a net cash position of -19.22 million.

Cash & Cash Equivalents	24.70M
Total Debt	43.92M
Net Cash	-19.22M
Net Cash Per Share	n/a
Equity (Book Value)	-59.11M
Book Value Per Share	-1.23
Working Capital	-19.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.68 million and capital expenditures -434,597, giving a free cash flow of -27.12 million.

Operating Cash Flow	-26.68M
Capital Expenditures	-434,597
Free Cash Flow	-27.12M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-432.39%
Pretax Margin	-508.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.33%
Shareholder Yield	-10.33%
Earnings Yield	-5.50%
FCF Yield	-3.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -2.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.82
Piotroski F-Score	1